{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:30:41Z","timestamp":1791862241178,"version":"4.3.4"},"reference-count":31,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"abstract":"\n Importance<\/jats:title>\n Phenobarbital use for alcohol withdrawal syndrome is increasing, but its effectiveness and safety have largely been compared with lorazepam rather than against more pharmacokinetically similar long-acting, self-tapering benzodiazepines such as diazepam.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To emulate a clinical trial comparing patients randomized to phenobarbital vs diazepam for alcohol withdrawal syndrome.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This multicenter comparative effectiveness research study analyzed data from the Premier Healthcare Database (October 2022 to August 2024), representing 754 US acute care hospitals. Adult inpatients with a primary diagnosis of alcohol withdrawal syndrome present on admission who initiated phenobarbital or diazepam on the day of hospital admission were included.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Initiation of phenobarbital or diazepam on the day of hospital admission.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary effectiveness outcome was hospital length of stay in days. The primary safety outcome was invasive mechanical ventilation use. Secondary outcomes assessed treatment escalation, complications of severe alcohol withdrawal syndrome, and resource utilization. Targeted maximum likelihood estimation with ensemble machine learning was used to estimate marginal mean differences and risk differences between exposure groups.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 24\u202f643 patients (median [IQR] age, 45 [35-56] years; 18\u202f511 male [75.1%]), 11\u202f919 (48.4%) received phenobarbital and 12\u202f724 (51.6%) received diazepam on the day of admission. There were no differences in hospital length of stay (marginal mean, 4.1 vs 4.3 days; marginal mean difference, \u22120.21 [95% CI, \u22120.42 to 0.00] days) or invasive mechanical ventilation use (marginal risk, 3.1% vs 2.7%; marginal risk difference, 0.4% [95% CI, \u22120.7% to 1.4%]) between initiation of phenobarbital vs diazepam. Secondary outcomes were also not different between phenobarbital and diazepam, except for self-directed discharge, which was more frequent among those initiated on diazepam (marginal risk, 9.5% vs 12.6%; marginal risk difference, \u22123.1% [95% CI, \u22124.9% to \u22121.3%]).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this multicenter study of patients hospitalized for alcohol withdrawal syndrome, there were no differences in hospital length of stay or the need for invasive mechanical ventilation between initiation of phenobarbital vs diazepam. These results may suggest near therapeutic equivalence between phenobarbital and long-acting benzodiazepines.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamainternmed.2026.4939","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:30:34Z","timestamp":1791819034000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparative Effectiveness of Phenobarbital vs Diazepam for Alcohol Withdrawal Syndrome"],"prefix":"10.1001","author":[{"given":"Tess","family":"Bradley","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Feeney","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anica C.","family":"Law","sequence":"additional","affiliation":[{"name":"The Pulmonary Center, Department of Medicine, Chobanian & Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa F.","family":"Peterkin","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Chobanian & Avedisian School of Medicine, Boston, Massachusetts"},{"name":"Grayken Center for Addiction, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Fantasia","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes, Nutrition, & Weight Management, Department of Medicine, Chobanian & Avedisian School of Medicine, Boston, Massachusetts"},{"name":"Evans Center for Implementation and Improvement Sciences, Department of Medicine, Chobanian & Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan J.","family":"Walkey","sequence":"additional","affiliation":[{"name":"Division of Health Systems Sciences, Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Bosch","sequence":"additional","affiliation":[{"name":"The Pulmonary Center, Department of Medicine, Chobanian & Avedisian School of Medicine, Boston, Massachusetts"},{"name":"Evans Center for Implementation and Improvement Sciences, Department of Medicine, Chobanian & Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"issue":"10","key":"ioi260059r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.38128","article-title":"Incidence of hospitalizations involving alcohol withdrawal syndrome in a primary care population.","volume":"7","author":"Steel","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"4","key":"ioi260059r2","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1007\/s11606-025-09817-8","article-title":"Pharmacological interventions for alcohol withdrawal syndrome among hospitalized adults: a multicenter cohort study.","volume":"41","author":"Erfle","year":"2026","journal-title":"J Gen Intern Med"},{"issue":"9","key":"ioi260059r3","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1164\/rccm.202203-0466LE","article-title":"Phenobarbital for severe alcohol withdrawal syndrome: a multicenter retrospective cohort study.","volume":"206","author":"Bosch","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"ioi260059r4","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1513\/AnnalsATS.202102-121OC","article-title":"Implementation of a phenobarbital-based pathway for severe alcohol withdrawal: a mixed-method study.","volume":"18","author":"Bosch","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"ioi260059r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.28694","article-title":"Hospital-wide implementation, clinical outcomes, and safety of phenobarbital for alcohol withdrawal.","volume":"8","author":"Wolpaw","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"3","key":"ioi260059r6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jemermed.2012.07.056","article-title":"Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study.","volume":"44","author":"Rosenson","year":"2013","journal-title":"J Emerg Med"},{"key":"ioi260059r8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ADM.0000000000000668","article-title":"The ASAM clinical practice guideline on alcohol withdrawal management.","volume":"14","year":"2020","journal-title":"J Addict Med"},{"issue":"12","key":"ioi260059r9","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jama.2025.13350","article-title":"Transparent reporting of observational studies emulating a target trial\u2014the TARGET statement.","volume":"334","author":"Cashin","year":"2025","journal-title":"JAMA"},{"issue":"3","key":"ioi260059r12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/annalsats\/aaoaf044","article-title":"Validation of a charge-based algorithm for identifying days receiving invasive mechanical ventilation.","volume":"23","author":"Shi","year":"2026","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"ioi260059r13","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/annalsats\/aaoag066","article-title":"Improved agreement between in-hospital and time-delimited mortality by including hospice discharges.","volume":"23","author":"Law","year":"2026","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"ioi260059r14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1097\/MLR.0000000000001767","article-title":"Identifying Medicare beneficiaries with delirium.","volume":"60","author":"Moura","year":"2022","journal-title":"Med Care"},{"key":"ioi260059r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v051.i13","article-title":"tmle: an R Package for targeted maximum likelihood estimation.","volume":"51","author":"Gruber","year":"2012","journal-title":"J Stat Softw"},{"issue":"1","key":"ioi260059r16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1515\/1557-4679.1332","article-title":"Targeted minimum loss based estimator that outperforms a given estimator.","volume":"8","author":"Gruber","year":"2012","journal-title":"Int J Biostat"},{"key":"ioi260059r17","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1266424","article-title":"Sex difference in alcohol withdrawal syndrome: a scoping review of clinical studies.","volume":"14","author":"Unlu","year":"2023","journal-title":"Front Psychiatry"},{"issue":"2","key":"ioi260059r18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1124\/mol.109.056705","article-title":"Sex differences in the expression of hepatic drug metabolizing enzymes.","volume":"76","author":"Waxman","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"1","key":"ioi260059r19","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2024.632","article-title":"Race, ethnicity, and considerations for data collection and analysis in research studies.","volume":"8","author":"Sharghi","year":"2024","journal-title":"J Clin Transl Sci"},{"issue":"24","key":"ioi260059r20","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1001\/jama.2016.17700","article-title":"Negative Control outcomes: a tool to detect bias in randomized trials.","volume":"316","author":"Arnold","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"ioi260059r21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/00004714-198111000-00006","article-title":"Development of optimal treatment tactics for alcohol withdrawal. I. Assessment and effectiveness of supportive care.","volume":"1","author":"Shaw","year":"1981","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"ioi260059r22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0953-6205(99)00026-6","article-title":"Fever during alcohol withdrawal syndrome.","volume":"10","author":"Otero-Ant\u00f3n","year":"1999","journal-title":"Eur J Intern Med"},{"issue":"10","key":"ioi260059r23","first-page":"42","article-title":"Impact of alcohol consumption on blood indices: systematic review.","volume":"15","author":"Cs","year":"2025","journal-title":"Eur J Cardiovasc Med"},{"issue":"19","key":"ioi260059r24","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1001\/jama.2023.12914","article-title":"Red blood cell transfusion: 2023 AABB international guidelines.","volume":"330","author":"Carson","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"ioi260059r25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/acem.14788","article-title":"SAEM GRACE: phenobarbital for alcohol withdrawal management in the emergency department: A systematic review of direct evidence.","volume":"31","author":"Punia","year":"2024","journal-title":"Acad Emerg Med"},{"key":"ioi260059r26","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-026-04414-x","article-title":"Phenobarbital monotherapy vs benzodiazepines for alcohol withdrawal syndrome: a multicenter propensity-matched comparative effectiveness study.","author":"Grayeb","journal-title":"Intern Emerg Med"},{"issue":"9","key":"ioi260059r27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/10600280231221241","article-title":"Phenobarbital versus benzodiazepines for the treatment of severe alcohol withdrawal.","volume":"58","author":"Kessel","year":"2024","journal-title":"Ann Pharmacother"},{"issue":"4","key":"ioi260059r28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2026.101769","article-title":"Safety and effectiveness of phenobarbital vs. benzodiazepines for severe alcohol withdrawal in alcohol-associated liver disease in the ICU.","volume":"8","author":"Govalan","year":"2026","journal-title":"JHEP Rep"},{"issue":"6","key":"ioi260059r29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008537.pub2","article-title":"Efficacy and safety of pharmacological interventions for the treatment of the alcohol withdrawal syndrome.","volume":"2011","author":"Amato","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"ioi260059r30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.29399\/npa.25077","article-title":"Readmission rates and causes within the first six months after discharge in patients with alcohol addiction.","volume":"58","author":"Genis","year":"2020","journal-title":"Noro Psikiyatr Ars"},{"issue":"3","key":"ioi260059r31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11606-014-2968-9","article-title":"An inpatient treatment and discharge planning protocol for alcohol dependence: efficacy in reducing 30-day readmissions and emergency department visits.","volume":"30","author":"Wei","year":"2015","journal-title":"J Gen Intern Med"},{"key":"ioi260059r7","unstructured":"Hoffman? RS, Weinhouse? GL. . Management of moderate and severe alcohol withdrawal syndromes. Wolters Kluwer. Updated March 3, 2019. Accessed September 9, 2026. https:\/\/www.scribd.com\/document\/402933844\/Management-of-Moderate-and-Severe-Alcohol-Withdrawal-Syndromes-UpToDate"},{"key":"ioi260059r10","unstructured":"Premier Applied Sciences. Premier healthcare database: data that informs and performs. Published March 2, 2020. Accessed July 27, 2026. https:\/\/www.healthcareview.media\/uploads\/resources\/resources\/4222021125431AM_Resource_PremierHealthcareDatabaseDataThatInformsAndPerforms.pdf"},{"key":"ioi260059r11","unstructured":"Premier Inc. Accessed May 20, 2026. https:\/\/premierinc.com\/"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2854918\/jamainternal_bradley_2026_oi_260059_1790709750.49426.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:30:37Z","timestamp":1791819037000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2854918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":31,"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2026.4939","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,12]]}}}